These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Audiological Monitoring in Children Treated with Platinum Chemotherapy. Fetoni AR, Ruggiero A, Lucidi D, De Corso E, Sergi B, Conti G, Paludetti G. Audiol Neurootol; 2016 Oct; 21(4):203-211. PubMed ID: 27286730 [Abstract] [Full Text] [Related]
6. Effect of high-dose cisplatin on auditory brainstem responses and otoacoustic emissions in laboratory animals. Sockalingam R, Freeman S, Cherny TL, Sohmer H. Am J Otol; 2000 Jul; 21(4):521-7. PubMed ID: 10912698 [Abstract] [Full Text] [Related]
12. Incidence and associated risk factors for platinum-induced ototoxicity in pediatric patients. Waissbluth S, Del Valle Á, Chuang A, Becker A. Int J Pediatr Otorhinolaryngol; 2018 Aug; 111():174-179. PubMed ID: 29958605 [Abstract] [Full Text] [Related]
13. The protective effects of intratympanic dexamethasone and vitamin E on cisplatin-induced ototoxicity are demonstrated in rats. Paksoy M, Ayduran E, Sanlı A, Eken M, Aydın S, Oktay ZA. Med Oncol; 2011 Jun; 28(2):615-21. PubMed ID: 20300971 [Abstract] [Full Text] [Related]
14. Cisplatin ototoxicity: the importance of baseline audiometry. Nagy JL, Adelstein DJ, Newman CW, Rybicki LA, Rice TW, Lavertu P. Am J Clin Oncol; 1999 Jun; 22(3):305-8. PubMed ID: 10362343 [Abstract] [Full Text] [Related]
15. High frequency audiometry in prospective clinical research of ototoxicity due to platinum derivatives. van der Hulst RJ, Dreschler WA, Urbanus NA. Ann Otol Rhinol Laryngol; 1988 Jun; 97(2 Pt 1):133-7. PubMed ID: 3281541 [Abstract] [Full Text] [Related]